Categories: News

Evotec Provides Update on Financial Impact of Cyber-Attack

HAMBURG, GERMANY / ACCESSWIRE / July 27, 2023 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces that it is adjusting its guidance for the fiscal year 2023.

Due to the impact of the cyber-attack, the company now expects Group revenues in the range of € 750 – 790 m (previously € 820 – 840 m); unpartnered R&D is expected in a range of € 60 – 70 m (previously € 70 – 80 m); and the adjusted EBITDA is expected to reach € 60 – 80 m (previously € 115 – 130 m).

While one-off items are affecting the outlook for 2023, optimisation measures are set to unfold their positive impact over to course of 2024 and beyond. Action Plan 2025 stays unchanged, targeting revenues of more than € 1 bn and an adjusted EBITDA of more than € 300 m.

Contact:

Dr Werner Lanthaler
Chief Executive Officer
Evotec SE
Manfred Eigen Campus
Essener Bogen 7, 22419
Hamburg, Germany
Phone: +49.(0)40.560 81-0
werner.lanthaler@evotec.com

SOURCE: Evotec SE

View source version on accesswire.com:
https://www.accesswire.com/770736/Evotec-Provides-Update-on-Financial-Impact-of-Cyber-Attack

Staff

Recent Posts

Empowering Latino Leaders: LCF Georgia’s Second Civic Participation Fellowship Program

LCF Georgia's Civic Participation Fellowship Program: 21 Fellows Trained in Civic Engagement and Community OrganizingATLANTA,…

10 mins ago

Horizon Treatment Services Ushers in a New Era of Inclusion With Drop-in Center for LGBTQIA+ Youth

Safe Haven for Youth and Young AdultsHAYWARD, CA / ACCESSWIRE / June 25, 2024 /…

10 mins ago

Lions Celebrate a Successful Year of Service at the 106th Lions International Convention

OAK BROOK, Ill., June 25, 2024 /PRNewswire/ -- Lions International celebrated several milestones during the…

3 hours ago

INDUSTRY LEADER IN PATIENT CENTRICITY CALLS FOR ITS SYSTEM-WIDE ADOPTION IN NEW BOOK

Dr. Anthony Yanni publishes a wide-ranging case for patient-centered healthcare delivery and treatment development—a "long-overdue…

3 hours ago

CUNY SPH receives $5.2 million NIH grant renewal for cancer genomics research

NEW YORK, June 25, 2024 /PRNewswire/ -- The Informatics Technology for Cancer Research (ITCR) program…

3 hours ago

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

World's First AI to Detect 35 Cardiac Determinations, Including Heart Attack, Using a Reduced Leadset…

3 hours ago